国际麻醉学与复苏杂志   2012, Issue (4): 5-5
    
肾缺血后处理对热休克蛋白表达的影响及作用
郭琼梅, 赵砚丽, 张东, 王振显, 岳立辉1()
1.河北省人民医院
Effect of ischemic postconditioning on expression of HSPs in rats after kidney ischemia reperfusion injury
 全文:
摘要:

目的 评价肾缺血后处理(ischemic postconditioning, IPo)对热休克蛋白(heat shock protein, HSP)70、HSP27和血红素加氧酶-1(heme oxygenase-1,HO-1,即HSP32)表达的影响及在减轻肾缺血再灌注(ischemia reperfusion, I/R)损伤中的作用。方法 健康雄性SD大鼠140只,体重250~280 g,采用随机数字表法随机分为4组(n=35):假手术组(S组)仅开腹,游离双侧肾脏,分离双侧肾蒂不夹闭;I/R组,夹闭双侧肾蒂缺血45 min,恢复灌注;IPo组,夹闭双侧肾蒂45 min,再灌注10 s,缺血10 s,反复3次,恢复灌注;HSP抑制剂槲皮黄酮+IPo组(Q+IPo组)缺血前1 h腹腔注射槲皮黄酮100 mg/kg,余操作同IPo组。于再灌注即刻(T0)、1、3、6、12、24、48 h(T1~6)时取5只大鼠经心脏抽血后迅速处死取肾,采用RT-PCR和免疫组织化学法分别检测各时点肾组织HSP70、HSP27和HO-1 的mRNA和蛋白表达,测定T3时血清肌酐(creatinine, Cr)和尿素氮(urea nitrogen, BUN)浓度、肾组织丙二醛(methylene dioxyamphetamine, MDA)含量和超氧化物歧化酶(superoxide dismutase, SOD)活性、肾组织核因子 кB(nuclear factor-kappa B, NF-кB)表达和血清肿瘤坏死因子-α(tumor necrosis factor α, TNF-α)浓度,光镜下观察肾组织病理学结果。结果 S组HSP70、HSP27和HO-1的mRNA有微量表达,蛋白几乎无表达,其余组在T0时开始表达,逐渐升高,T3时达高峰,随后逐渐下降。与S组比较,其余组各时点HSP70、HSP27和HO-1 的mRNA和蛋白表达上调(P﹤0.05),IPo组较I/R组T2~5时HSP70、HSP27和HO-1 的mRNA和蛋白表达上调(P﹤0.05),Q+IPo组较IPo组T2~5时HSP70、HSP27和HO-1 的mRNA和蛋白表达下调(P﹤0.05)。T3时血清Cr、BUN和TNF-α浓度I/R组分别为(102±5)µmol/L、(25.7±3.9)mmol/L、(2.29±0.18)ng/ml,IPo组分别为(64±5)µmol/L、(11.3±3.0)mmol/L、(1.76±0.13)ng/ml,Q+IPo组分别为(101±6)µmol/L、(26.5±4.5)mmol/L、(2.31±0.17 )ng/ml,均高于S组(46±6)µmol/L、(5.1±1.9)mmol/L和(1.13±0.14)ng/ml(P﹤0.05),IPo组三者浓度较I/R组降低(P﹤0.05),Q+IPo组较IPo组升高(P﹤0.05)。T3时MDA含量I/R组(2.20±0.23 )nmol/mgprot、IPo组(1.35±0.13 )nmol/mgprot和Q+IPo组(2.25±0.16)nmol/mgprot较S组(1.02±0.19)nmol/mgprot升高(P﹤0.05),SOD活性I/R组(104±6)U/mgprot、IPo组(124±4)U/mgprot和Q+IPo组(106±5)U/mgprot较S组(147±6)U/mgprot降低(P﹤0.05),IPo组与I/R组比较MDA含量降低和SOD活性升高(P﹤0.05),Q+IPo组与IPo组比较MDA含量升高和SOD活性降低(P﹤0.05),肾组织NF-кB表达I/R组、IPo组和Q+IPo组较S组增高,IPo组较I/R组表达降低,Q+IPo组较IPo组表达增高(P﹤0.05)。I/R组与Q+IPo组相比,各指标差异无统计学意义(P>0.05)。与S组比较,其余三组有程度不等的肾组织病理学损伤,IPo组损伤较I/R组减轻,Q+IPo组损伤程度与I/R组相似。结论 IPo上调了HSP70、HSP27和HO-1的表达;HSP高表达参与了肾IPo减轻肾I/R损伤的过程

关键词: 缺血后处理; 再灌注损伤;肾;热休克蛋白
Abstract:

Obiective To investigate the effect of ischemic postconditioning on expression of heat shock protein (HSP)70, HSP27 and HO-1 (heme oxygenase-1) and the role of which in reduction renal ischemia-reperfusion (I/R) injury in rats. Methods One hundred forty healthy male SD rats weighing 250-280 g were randomly divided into 4 groups (n=35 each) : group I sham operation group (group S); group II I/R; group III IPo; group IV quercetin+IPo group (group Q+IPo). The rats were anesthetized with intraperitoneal (IP) chloral hydrate 300 mg/kg. Bilateral kidneys were exposed and their pedicels were clamped for 45 min followed by reperfusion in group II-IV. In group III and IV 3 cycles of 10 s reperfusion followed by 10 s ischemia were applied immediately after 45 min kidney ischemia. In group IV quercetin (a inhibitor of HSP) 100 mg/kg was given IP at 30 min before ischemia. Five rats were sacrificed at 0, 1, 3, 6, 12, 24, and 48 h (T0-6) of reperfusion and the kidneys were immediatedly removed for determination the expression of HSP70mRNA, HSP27mRNA, HO-1 mRNA, HSP70, HSP27 and HO-1. At T3 before the rats were sacrificed blood samples were obtained for determination of serum creatinine(Cr), urea nitrogen (BUN) and tumor necrosis factor α (TNF-α) concentrations and kidneys were removed for determination of the expression of nuclear factor-kappa B (NF-кB), the methylene dioxyamphetamine (MDA) content and superoxide dismutase (SOD) activity, and observation of histopathology with light microscope. Results The expression of HSP70mRNA, HSP27mRNA, HO-1 mRNA, HSP70, HSP27 and HO-1 was traced in group S, and in the other three groups the expression of HSP70mRNA、HO-1mRNA and HSP70、HO-1 increased at T1 and meet peakpoint at T3, then begain to decreased. Compared with group S, the expression of HSP70mRNA, HSP27mRNA, HO-1mRNA, HSP70, hsp27 and HO-1 was up-regulated at T0-6 in other 3 groups (P<0.05), Compared with group I/R, the expression of HSP70mRNA, HSP27mRNA, HO-1mRNA, HSP70, hsp27 and HO-1 was up-regulated at T2-5 in group IPo (P<0.05), Compared with group IPo, the expression of HSP70mRNA, HSP27mRNA, HO-1mRNA, HSP70, hsp27 and HO-1 was down-regulated at T2-5 in group Q+IPo (P<0.05). There were not significant defferent between group I/R and group Q+IPo (P>0.05). Serum Cr, BUN and TNF-α concentrations at T3 in group I/R (102±5) µmol/L, (25.7±3.9) mmol/L, (2.29±0.18) ng/ml, in group IPo (64±5) µmol/L, (11.3±3.0) mmol/L, (1.76±0.13) ng/ml, and in grou Q+IPo(101±6) µmol/L, (26.5±4.5) mmol/L, (2.31±0.17) ng/ml were increased than those in group S (46±6) µmol/L, (5.1±1.9) mmol/L and (1.13±0.14) ng/ml(P﹤0.05), and the serum Cr, BUN and TNF-α concentrations in group IPo were decreased than those in group I/R, and those in group Q+IPo were increased than those in group IPo (P﹤0.05). There were not significant defferent between group I/R and group Q+IPo (P>0.05). The MDA content (2.20±0.23) nmol/mgprot in group I/R, (1.35±0.13) nmol/mgprot in group IPo and (2.25±0.16) nmol/mgprot in group Q+IPo was in creased than that in group S (P﹤0.05), the activity of SOD (104±6) U/mgprot in group I/R, (124±4) U/mgprot in group IPo and (106±5) U/mgprot in group Q+IPo was decreased than that in group S (P﹤0.05); the MDA content was decreased and SOD activity was increased in group IPo compared with group I/R, and the MDA content was increased and SOD activity was decreased in group Q+IPo compared with group IPo (P﹤0.05). The expression of NF-кB in group was up-regulated at T3 in group I/R, IPo and Q+IPo compared with group S, that in group IPo was down-regulated compared with group I/R, and that in Q+IPo was up-regulated compared with group IPo (P﹤0.05). There were not significant defferent between group I/R and group Q+IPo (P>0.05). Microscope examination showed that the injury to kidney was attenuated in group IPo compared with group I/R, the injury to kidney was not significant defferent between group I/R and group Q+IPo. Conclusion IPo increased the expression of HSP70, HSP27, and HO-1 and the expression of HSP is involved in the reduction of renal I/R injury by IPo in rats.

Key words: Ischemic postconditioning; Ischemic reperfusion injury; Renal; Heat shock protein